Affiliation:
1. FSBSI “Mental Health Research Centre”
Abstract
Background: the clinical experience testifies to the fact, that the increase of dementia severity in late age occurs quickly in some cases and in others it proceeds slowly, which is reflected in the total duration of the disease and survival. One of the aspects of dementias research is the study of significant differences in dementia progression rates.The objective of the review was to generalize the obtained data on progression rates of late age dementias of various genesis, first of all due to Alzheimer’s disease and its associated disorders.Material and methods: papers in MedLine/PubMed bases from1990 to 2020 were selected and analyzed according to the key words: “old age”, “dementia”, “Alzheimer’s disease”, “vascular dementia”, “progression”, “progression rate”, “disease trajectories”, as well as relevant papers in the references of the analyzed works.Conclusion: the history of research of old age dementias natural course was presented in the review of scientific publications. According to the results of development of progression rates detection methods, singling out of dementias with rapid and slow increase in the severity of cognitive decline was substantiated. Works devoted to the study of frequency and nosological belonging of dementias with different progression rates were considered. In the most recent studies prognostic models with detection of various trajectories of the course of the disease were developed. The concept of various dementias progression rates admittedly has practical meaning for provision of diagnostic and treatment assistance and planning of medical and social support measures for patients with dementia and their families. Differentiation of dementia progression clinical patterns during formation of comparable groups of patients seems appropriate for investigation of new therapy methods, as well as in clinical-biological studies of pathogenesis.
Publisher
Medical Informational Agency Publishers
Reference16 articles.
1. Gavrilova SI. Approaches to preventive treatment of Alzheimer’s disease: problems and possibilities. Psychiatry. 2014;61(01):5–12. (In Russ.).
2. Gavrilova SI. Pre-dementia neurocognitive disorder: diagnostic and therapeutic aspects. V.M. Bekhterev review of psychiatry and medical psychology. 2018;(1):89–98. (In Russ.).
3. Bachurin, SO, Gavrilova, SI, Samsonova, A, Barreto GE, Aliev G. Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention. Pharmacological Research. 2018;129:216–226. DOI: 10.1016/j.phrs.2017.11.021
4. Dubois B, Feldman HH, Jacova C et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–629. DOI: 10.1016/S1474-4422(14)70090-0
5. Jack C, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers Neurology. 2016;87(5):539–547. DOI: 10.1212/WNL.0000000000002923